Proteas Bioanalytics Inc. — Form D
Proteas Bioanalytics Inc. of Torrance, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-13. The offering totals $3.0M, of which $365K was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-03-13
- Form: D
- Accession: 0001831825-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $365K
- Remaining: $2.6M
- Investors: 5
- Date of first sale: 2022-08-11
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-475680
Issuer
- Name: Proteas Bioanalytics Inc.
- CIK: 0001831825
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: Biolabs at the Lundquist Institute, Torrance, CA, 90502
- Phone: 626-200-7238
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Valerie Darling | Director | Torrance, CA |
| Spiros Garbis | Director | Torrance, CA |
| Antigoni Manousopoulou | Director | Torrance, CA |
| Spiros Garbis | Executive Officer | Torrance, CA |
| Spiros D Garbis | Director | Torrance, CA |
| Spiros D Garbis | Executive Officer | Torrance, CA |
| Keith B Hoffman | Director | Torrance, CA |
| Dimitrios D Iliopoulos | Director | Torrance, CA |
Other filings by this issuer (2)
More